Nerlynx (neratinib)

pCPA File Number: 21178
Negotiation Status:
Negotiations were not pursued
Indication(s):
Hormone Receptor-Positive Breast Cancer
Sponsor/Manufacturer:
Knight Therapeutics
CADTH Project Number:
10172
pCPA Engagement Letter Issued:
Negotiation Process Concluded: